Advanced progress in research and diagnosis of gastric cancer in 2022
Gastric cancer is one of the malignant tumors with high incidence in China, with a 5-year relative survival rate of about 40%, which is characterized by low early diagnosis rate, large tumor load, high heterogeneity and poor prognosis. In the past 20 years, the multidisciplinary team model and indiv...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of China Oncology
2023-04-01
|
Series: | Zhongguo aizheng zazhi |
Subjects: | |
Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1684137939099-982572506.pdf |